Addition of manual daytime exchanges to automated peritoneal dialysis (APD) regimens optimizes solute clearance, but reduces quality of life and might increase the risk of peritonitis. Clinically ...

Please provide your email address to receive an email when new articles are posted on . In the United States, the annual rate of growth in incident patients with end-stage kidney disease has slowed.

First patients have been enrolled in the clinical trial for next generation dialysis technology Innovative system designed to improve home dialysis experience and simplify therapy management New ...

Peritoneal dialysis (PD) continues its slow march toward equal popularity within the nephrology community. In most areas of the United States, it is still the minority to the behemoth that is ...

For most people, hemodialysis and peritoneal dialysis are equally effective treatments for end stage renal disease. Factors such as your health, preferences, and the costs may influence your final ...

Kidney disease affects millions globally, often reducing quality of life and daily functioning. In the United States, about 14% of adults have chronic kidney disease (CKD), according to the National ...

The US Food and Drug Administration (FDA) has cleared Baxter International's AMIA automated home peritoneal dialysis (APD) system with remote connectivity over the Internet, using the company's ...

End-stage renal disease (ESRD) is the final stage of chronic kidney disease. It results in irreversible kidney impairment and causes a significant decline in urine production and glomerular filtrate ...

According to the U.S. Renal Data System, peritoneal dialysis is less expensive than hemodialysis. One year of hemodialysis can cost up to $72,000, while a year of peritoneal dialysis costs about ...

Kidney disease impacts millions globally. Two main treatments, hemodialysis and peritoneal dialysis, offer life-saving solutions. Hemodialysis uses a machine to filter blood, while peritoneal dialysis ...